Rhabdomyolysis: Difference between revisions

No edit summary
Line 5: Line 5:


===Etiology===
===Etiology===
#Trauma or muscle compression
*Trauma or muscle compression
##[[Crush Syndrome]]
**[[Crush Syndrome]]
##Immobilization
**Immobilization
##[[Compartment Syndrome]]
**[[Compartment Syndrome]]
#Nontraumatic Exertional
*Nontraumatic Exertional
##Exercise + hot weather
**Exercise + hot weather
##Exercise + sickle cell
**Exercise + sickle cell
##Exercise + [[Hypokalemia]]
**Exercise + [[Hypokalemia]]
##Hyperkinetic states
**Hyperkinetic states
###[[Seizure]]
***[[Seizure]]
###DTs
***DTs
###Stimulant overdose
***Stimulant overdose
###[[Malignant Hyperthermia]]
***[[Malignant Hyperthermia]]
###Neuroleptic malignant syndrome
***Neuroleptic malignant syndrome
#Nontraumatic Nonexertional
*Nontraumatic Nonexertional
##Drugs and toxins
**Drugs and toxins
###Coma induced by sedatives
***Coma induced by sedatives
###Alcohol
***Alcohol
####Coma-induced muscle compression
****Coma-induced muscle compression
####Direct toxic effect
****Direct toxic effect
####Nutritional compromise increases risk (hypoK, hypoMg, HypoPhos)
****Nutritional compromise increases risk (hypoK, hypoMg, HypoPhos)
###Statins
***Statins
###Colchicine   
***Colchicine   
###[[CO Poisoning]]
***[[CO Poisoning]]
##Infection
**Infection
###Viral myositis - Influenza, Coxsackie, EBV, HSV, HIV, CMV
***Viral myositis - Influenza, Coxsackie, EBV, HSV, HIV, CMV
###Bacterial pyomyositis
***Bacterial pyomyositis
###Septicemia
***Septicemia
##Endocrine
**Endocrine
###[[Hypothyroidism]]
***[[Hypothyroidism]]
##Inflammatory myopathies
**Inflammatory myopathies
###Moderate CK elevations only (rhabdo only described in case reports)
***Moderate CK elevations only (rhabdo only described in case reports)
##Miscellaneous
**Miscellaneous
###[[Status Asthmaticus]]
***[[Status Asthmaticus]]
###TSS
***TSS
###Mushroom ingestion
***Mushroom ingestion


==Differential Diagnosis==
==Differential Diagnosis==
Line 46: Line 46:


==Clinical Features==
==Clinical Features==
#Myalgia, stiffness, weakness, malaise, low-grade fever, dark urine
*Myalgia, stiffness, weakness, malaise, low-grade fever, dark urine
##Musculoskeletal symptoms may be present in only half of cases
**Musculoskeletal symptoms may be present in only half of cases
#N/V, abd pain, tachycardia in severe cases
*N/V, abd pain, tachycardia in severe cases
#Mental status changes secondary to urea-induced encephalopathy
*Mental status changes secondary to urea-induced encephalopathy


==Work-up==
==Work-up==
#Total CK
*Total CK
#UA
*UA
#CBC
*CBC
#Chemistry, including Mag, Phos
*Chemistry, including Mag, Phos
#Uric acid
*Uric acid
#LFTs
*LFTs
#DIC panel
*DIC panel
##Coags, FSP, fibrinogen
**Coags, FSP, fibrinogen


==Diagnosis==
==Diagnosis==
#Total CK
*Total CK
##Most consider rhabdo if 5x or greater increase above upper limit of normal (~2000)
**Most consider rhabdo if 5x or greater increase above upper limit of normal (~2000)
##Serum CK begins to rise 2-12hr after injury, peaks w/in 24-72hr
**Serum CK begins to rise 2-12hr after injury, peaks w/in 24-72hr
##Degree of CK elevation correlates w/ muscle injury, but NOT renal failure
**Degree of CK elevation correlates w/ muscle injury, but NOT renal failure
#CK-MB
*CK-MB
##May be normal or mildly elevated (<5% of total)
**May be normal or mildly elevated (<5% of total)
#Uric Acid - elevates before CK
*Uric Acid - elevates before CK
#Myoglobinuria
*Myoglobinuria
##UA = +blood, no RBCs (Sn ~80%)  
**UA = +blood, no RBCs (Sn ~80%)  
##Myoglobin is cleared w/in 1-6hr (often see elevated CK with no myoglobinuria)
**Myoglobin is cleared w/in 1-6hr (often see elevated CK with no myoglobinuria)
#Acute renal failure
*Acute renal failure
##Creatinine increase
**Creatinine increase
#Electrolyte abnormalities
*Electrolyte abnormalities
##[[Hyperkalemia]]
**[[Hyperkalemia]]
##Hyperphosphatemia
**Hyperphosphatemia
##[[Hypocalcemia]]
**[[Hypocalcemia]]
##Hyperuricemia
**Hyperuricemia


==Management==
==Management==
#Aggressive IVF
*Aggressive IVF
##Start with NS 1-2 L/hr
**Start with NS 1-2 L/hr
##Once diuresis occurs maintain urine output of 200-300 mL/hr
**Once diuresis occurs maintain urine output of 200-300 mL/hr
##Frequently need ~10 L/day
**Frequently need ~10 L/day
#Trend:
*Trend:
##Volume status
**Volume status
##Urine pH
**Urine pH
##Chemistry  
**Chemistry  
##CK
**CK
##Calcium, phosphorus
**Calcium, phosphorus
#[[Urinary alkalinization]] (with bicarbonate)
*[[Urinary alkalinization]] (with bicarbonate)
##Controversial; no RCT to date have demonstrated benefit
**Controversial; no RCT to date have demonstrated benefit
##Consider if CK >5000, severe muscle injury (crush injury), rising CK AND urine pH <6.5
**Consider if CK >5000, severe muscle injury (crush injury), rising CK AND urine pH <6.5
##Contraindications:
**Contraindications:
###Severe hypocalcemia
***Severe hypocalcemia
###Arterial pH > 7.50
***Arterial pH > 7.50
###Serum bicarbonate > 30 meq/L
***Serum bicarbonate > 30 meq/L
##Mix 150 mL [3 amps] of 8.4% sodium bicarbonate w/ 1 L D5W
**Mix 150 mL [3 amps] of 8.4% sodium bicarbonate w/ 1 L D5W
##Infuse at 200 mL/hour; rate is adjusted to achieve urine pH of >6.5
**Infuse at 200 mL/hour; rate is adjusted to achieve urine pH of >6.5
##Arterial pH and serum calcium should be monitored q2hr
**Arterial pH and serum calcium should be monitored q2hr
##Discontinue if:
**Discontinue if:
###Urine pH does not rise above 6.5 after 3-4hr
***Urine pH does not rise above 6.5 after 3-4hr
###Pt develops symptomatic hypocalcemia
***Pt develops symptomatic hypocalcemia
###Arterial pH > 7.5
***Arterial pH > 7.5
###Serum bicarbonate >30 meq/L
***Serum bicarbonate >30 meq/L
#[[Mannitol]]
*[[Mannitol]]
##Controversial; no RCT to date has demonstrated benefit
**Controversial; no RCT to date has demonstrated benefit
##Mannitol administration can worsen dehydration and oliguria, cause hyperkalemia
**Mannitol administration can worsen dehydration and oliguria, cause hyperkalemia
##Consider in pts w/marked elevations in CK (>30K)
**Consider in pts w/marked elevations in CK (>30K)
##Contraindicated if urinary flow is inadequate (<20 mL/hr)
**Contraindicated if urinary flow is inadequate (<20 mL/hr)
##Add 50 mL of 20% mannitol to each liter of fluid; give at rate of 5g/hr
**Add 50 mL of 20% mannitol to each liter of fluid; give at rate of 5g/hr
##Must check plasma osmolaity and plasma osmolal gap q4-6hr
**Must check plasma osmolaity and plasma osmolal gap q4-6hr
###Discontinue if osmolal gap > 55 mosmol/kg
***Discontinue if osmolal gap > 55 mosmol/kg
#Intubation/RSI
*Intubation/RSI
##Use Rocuronium
**Use Rocuronium


==Disposition==
==Disposition==
#Discharge if:
*Discharge if:
##Exertional rhabdo
**Exertional rhabdo
##Otherwise healthy
**Otherwise healthy
##No comorbidities (heat stress, dehydration, trauma)
**No comorbidities (heat stress, dehydration, trauma)
##Downtrending total CK
**Downtrending total CK
###Consider admission for CK >30,000
***Consider admission for CK >30,000
#Otherwise admit to monitored bed
*Otherwise admit to monitored bed


==Complications==
==Complications==
#[[Acute Renal Failure]]
*[[Acute Renal Failure]]
##Neither presence of myoglobinuria nor degree of CK rise is predictive of ARF
**Neither presence of myoglobinuria nor degree of CK rise is predictive of ARF
##Rare in exertional rhabdo w/o presence of dehydration, heat stress, trauma
**Rare in exertional rhabdo w/o presence of dehydration, heat stress, trauma
##Most commonly oliguric
**Most commonly oliguric
#[[Hyperkalemia]]
*[[Hyperkalemia]]
##Renal function, not release of K+, is most important determinant
**Renal function, not release of K+, is most important determinant
##Treat aggressively; insulin may be ineffective; may require dialysis
**Treat aggressively; insulin may be ineffective; may require dialysis
#[[Hypocalcemia]] (initial phase)
*[[Hypocalcemia]] (initial phase)
##Treat only if symptomatic or severely hyperkalemic (often have rebound hypercalcemia)
**Treat only if symptomatic or severely hyperkalemic (often have rebound hypercalcemia)
#[[Hypercalcemia]] (recovery phase)
*[[Hypercalcemia]] (recovery phase)
#[[Hyperphosphatemia]]
*[[Hyperphosphatemia]]
##Treat cautiously (treatment may worsen calcium precipitation in muscle)
**Treat cautiously (treatment may worsen calcium precipitation in muscle)
##Consider oral phosphate binders when level >7
**Consider oral phosphate binders when level >7
#[[DIC]]
*[[DIC]]
##Usually resolves spontaneously w/in several days
**Usually resolves spontaneously w/in several days
#[[Compartment Syndrome]]
*[[Compartment Syndrome]]
#Peripheral nerve injury
*Peripheral nerve injury
##Usually resolves w/in few days-weeks
**Usually resolves w/in few days-weeks


==See Also==
==See Also==
Line 150: Line 150:
*[[Sympathomimetic Toxicity]]
*[[Sympathomimetic Toxicity]]


==Source==
==References==
*Tintinalli
*UpToDate


[[Category:Nephro]]
[[Category:Nephro]]
[[Category:Trauma]]
[[Category:Trauma]]

Revision as of 14:00, 20 July 2015

Background

  • Muscle necrosis and release of intracellular muscle constituents into the circulation
  • Recurrent episodes suggests inherited metabolic disorder
  • Alcohol and drugs play a role in up to 80% of cases

Etiology

  • Trauma or muscle compression
  • Nontraumatic Exertional
  • Nontraumatic Nonexertional
    • Drugs and toxins
      • Coma induced by sedatives
      • Alcohol
        • Coma-induced muscle compression
        • Direct toxic effect
        • Nutritional compromise increases risk (hypoK, hypoMg, HypoPhos)
      • Statins
      • Colchicine
      • CO Poisoning
    • Infection
      • Viral myositis - Influenza, Coxsackie, EBV, HSV, HIV, CMV
      • Bacterial pyomyositis
      • Septicemia
    • Endocrine
    • Inflammatory myopathies
      • Moderate CK elevations only (rhabdo only described in case reports)
    • Miscellaneous

Differential Diagnosis

Red or Purple Urine

Clinical Features

  • Myalgia, stiffness, weakness, malaise, low-grade fever, dark urine
    • Musculoskeletal symptoms may be present in only half of cases
  • N/V, abd pain, tachycardia in severe cases
  • Mental status changes secondary to urea-induced encephalopathy

Work-up

  • Total CK
  • UA
  • CBC
  • Chemistry, including Mag, Phos
  • Uric acid
  • LFTs
  • DIC panel
    • Coags, FSP, fibrinogen

Diagnosis

  • Total CK
    • Most consider rhabdo if 5x or greater increase above upper limit of normal (~2000)
    • Serum CK begins to rise 2-12hr after injury, peaks w/in 24-72hr
    • Degree of CK elevation correlates w/ muscle injury, but NOT renal failure
  • CK-MB
    • May be normal or mildly elevated (<5% of total)
  • Uric Acid - elevates before CK
  • Myoglobinuria
    • UA = +blood, no RBCs (Sn ~80%)
    • Myoglobin is cleared w/in 1-6hr (often see elevated CK with no myoglobinuria)
  • Acute renal failure
    • Creatinine increase
  • Electrolyte abnormalities

Management

  • Aggressive IVF
    • Start with NS 1-2 L/hr
    • Once diuresis occurs maintain urine output of 200-300 mL/hr
    • Frequently need ~10 L/day
  • Trend:
    • Volume status
    • Urine pH
    • Chemistry
    • CK
    • Calcium, phosphorus
  • Urinary alkalinization (with bicarbonate)
    • Controversial; no RCT to date have demonstrated benefit
    • Consider if CK >5000, severe muscle injury (crush injury), rising CK AND urine pH <6.5
    • Contraindications:
      • Severe hypocalcemia
      • Arterial pH > 7.50
      • Serum bicarbonate > 30 meq/L
    • Mix 150 mL [3 amps] of 8.4% sodium bicarbonate w/ 1 L D5W
    • Infuse at 200 mL/hour; rate is adjusted to achieve urine pH of >6.5
    • Arterial pH and serum calcium should be monitored q2hr
    • Discontinue if:
      • Urine pH does not rise above 6.5 after 3-4hr
      • Pt develops symptomatic hypocalcemia
      • Arterial pH > 7.5
      • Serum bicarbonate >30 meq/L
  • Mannitol
    • Controversial; no RCT to date has demonstrated benefit
    • Mannitol administration can worsen dehydration and oliguria, cause hyperkalemia
    • Consider in pts w/marked elevations in CK (>30K)
    • Contraindicated if urinary flow is inadequate (<20 mL/hr)
    • Add 50 mL of 20% mannitol to each liter of fluid; give at rate of 5g/hr
    • Must check plasma osmolaity and plasma osmolal gap q4-6hr
      • Discontinue if osmolal gap > 55 mosmol/kg
  • Intubation/RSI
    • Use Rocuronium

Disposition

  • Discharge if:
    • Exertional rhabdo
    • Otherwise healthy
    • No comorbidities (heat stress, dehydration, trauma)
    • Downtrending total CK
      • Consider admission for CK >30,000
  • Otherwise admit to monitored bed

Complications

  • Acute Renal Failure
    • Neither presence of myoglobinuria nor degree of CK rise is predictive of ARF
    • Rare in exertional rhabdo w/o presence of dehydration, heat stress, trauma
    • Most commonly oliguric
  • Hyperkalemia
    • Renal function, not release of K+, is most important determinant
    • Treat aggressively; insulin may be ineffective; may require dialysis
  • Hypocalcemia (initial phase)
    • Treat only if symptomatic or severely hyperkalemic (often have rebound hypercalcemia)
  • Hypercalcemia (recovery phase)
  • Hyperphosphatemia
    • Treat cautiously (treatment may worsen calcium precipitation in muscle)
    • Consider oral phosphate binders when level >7
  • DIC
    • Usually resolves spontaneously w/in several days
  • Compartment Syndrome
  • Peripheral nerve injury
    • Usually resolves w/in few days-weeks

See Also

References